We are a leading innovator of medical solutions that improve the health of patients around the world.
Our products and technologies are used to diagnose or treat a wide range of medical conditions, including heart, digestive, pulmonary, vascular, urological, women’s health, and chronic pain conditions.
We continue to innovate in these areas and are extending our innovations into new geographies and high-growth adjacency markets.
Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.
We act with integrity and compassion to support patients, customers, our communities and each other.
We foster an environment of creativity to transform new ideas into breakthrough services and solutions that create value for patients, customers and employees.
We strive for high performance to benefit our patients, clinicians and shareholders.
We work collaboratively to pursue global opportunities that extend the reach of our medical solutions.
We embrace diversity and value the unique talents, ideas and experiences of our employees.
We adapt to change and act with speed, agility and accountability to further improve patient care.
C.R. Bard Ltd. is a US multinational enterprise located in Ireland. We are a developer of innovative, life-enhancing medical technologies in the fields of Vascular, Urology, Oncology and Surgical Specialty products.
Cardiac Services Group is at the forefront of supplying and supporting diagnostic and measurement equipment in Ireland and the UK with specific focus on ICU, Coronary Care, theatre and maternity. The pre-hospital division specialises in the supply of AEDs, training devices and primary care / GP supplies. Cardiac Services was acquired by SISK GROUP in August 2006.
The SISK GROUP diversified into Healthcare in March 2006, acquiring five medical device distribution companies that operate under the umbrella structure, SISK Healthcare. These companies are: MED Surgical, Cardiac Services, TEKNO Surgical, Beaver Medical and Synapse Medical. It has a combined annual turnover of €100 million. It comprises over 208 employees, 113 in sales and support, 34 technicians, as well as a specific clinical training & educational dept.
Cardiogenics Ltd. was formed in April 2010. We are a team of highly motivated dynamic professionals with over 35 years’ experience and a proven track record within the Irish & UK distribution market. We provide our customers a “best in class” cardiac diagnostic testing and SSCD screen service, complimented by comprehensive training, education, innovative healthcare solutions and high quality products.
Our products include
- Provision of Cardiology Services to HSE, i.e. ECG, Echo, Stress Testing and Holter
- Cardiac Screening for SAD in Schools & Sports Clubs with a referral path to the major University Hospitals
- Z – Medica – Quikkclot Interventional Hemostatic Bandage and Emergency Dressings
- Vasomedical EECP – Enhanced External Counterpulsation
- BIOX Combined BP and Holter Monitor
- EZ ECG and SpO2 Monitors
Working Together with Care is our Motto. 2016 marks our 10 year anniversary and we are proud to have built up a reputation for quality products and excellent customer service in these 10 years. We offer unbeatable customer service while providing top quality healthcare equipment.
What do we do? We supply and service healthcare equipment and products to both the Irish and UK Healthcare Sector and the general public. Our products include; profiling hospital beds, pressure relief mattresses, patient lifting equipment, disabled baths, showering equipment, falls monitoring systems, bedpan washers, macerators and much more.
We also have a fully qualified team of engineers to service and maintain various healthcare products.
Call one of our dedicated friendly team members today, and see how we can help you!!
McKesson delivers vital medicines, medical supplies and health care information technology solutions that touch the lives of patients in every health care setting. McKesson is committed to creating a health care system that leads to lower costs, fewer mistakes, higher quality and better health for all.
Over the past decade, we have launched initiatives and solutions aimed at reshaping health care. Among some of these important initiatives:
- Our Health Mart® pharmacy franchise has changed the face of independent pharmacy, enabling independents to thrive in business while providing exemplary care and service to their communities.
- The US Oncology Network, part of McKesson Specialty Health, is advancing cancer care by expanding patient access to high-quality, integrated care among community-based oncology physicians. The network leverages technology, shared best practices, evidence-based guidelines and quality measurements.
- We recently entered into the CommonWell Health Alliance, a collaborative effort among health IT suppliers to reach common standards, seamless interoperability and data liquidity between electronic medical record (EMR) systems — an essential part of connecting health care providers for better clinical outcomes.
Coloplast Limited is a wholly owned subsidiary of Coloplast A/S of Denmark. Our headquarters and distribution centre are located on the outskirts of Peterborough, Cambridgeshire.
Coloplast Limited has responsibility for the sales, marketing and distribution of Coloplast Medical Devices (Stoma Care, Wound Care and Continence Care) in the United Kingdom and Ireland.
Coloplast is one of the world’s leading suppliers of intimate healthcare products and services. As a group, we have built our current position by listening to users and understanding their needs. For more than 50 years, Coloplast has developed and marketed innovative products that make life easier for people with diseases of a private nature.
Over 30 years ago, we began with a clear focus and a single mission: to improve the lives of the patients whose needs we meet. The creativity that drove us to envision and develop the world’s first two-piece disposable stoma pouching system in 1978, giving thousands of patients a renewed sense of dignity and freedom, is still very much a part of our culture and environment. Today, our mission remains the same: to create innovative healthcare solutions for better patient outcomes. …that lives in all of our brands.
Our extensive product line is designed to meet the needs of stoma and wound patients and the healthcare professionals who care for them. From the beginning, our products have been defined by their quality. As the world changes, so do the needs of patients and carers. By continuing to develop technologies to meet those needs, ConvaTec can provide new answers to our customers who operate on the front lines of an ever-changing healthcare environment.
Today our product range includes: AQUACEL®, AQUACEL Ag®, DuoDERM® Extra Thin, Versiva® XC™, Flexi-Seal® FMS, Natura®, Esteem®, Esteem Synergy®.
If you are interested in learning more about ConvaTec or the products we offer, please call us at:
+353 (0) 1 293 8931
+353 (0) 1 293 8944 (fax)
Stoma Care Helpline Freephone:
1 800 721 721
Wound Care Helpline Freephone:
1 800 946 938
Ireland – ConvaTec c/o Sangers
Distribution: 44 (0)28 9040 1111
Ireland – ConvaTec c/o United Drug Distributors: 353 (0)1463 2300and ask to be added to our mailing list
Critical Healthcare Limited strives to be the first choice for Emergency Medical Professionals. It is an Irish company offering a comprehensive range of emergency medical products and services to the pre-hospital market, and ambulance providers in Ireland and more recently the UK and Europe.
In today’s healthcare environment healthcare services and organisations need to deliver effective and cost-efficient patient care. Critical Healthcare is committed to working with healthcare professionals in designing and developing new products and services to ensure a safer and risk free environment for the service providers and the patient alike.
The key to Critical Healthcare’s success has been our ability to respond quickly and efficiently to our clients’ changing requirements. Proactive contract and supplier management, product rationalisation and superior materials management ensure that our services meet your bespoke requirements and guarantee optimum performance.
Cruinn Diagnostics Limited is a solely Irish owned company which was established in 1998 with the aim of providing top quality products and premium service to its customers.
In partnership with some of the leading manufacturers from across the world, Cruinn Diagnostics Limited quickly established itself as one of Ireland’s leading distributors of Laboratory supplies and equipment to the Clinical, Industrial, Pharmaceutical, Veterinary, University and Research industries.
More recently CruinnCal was set up as a division of Cruinn Diagnostics Limited to provide a range of Calibraton and Testing services to our growing customer base. In February 2011 Cruinn Diagnostics Limited was awarded accreditation by the Irish National Accreditation Board (INAB) to undertake Calibration and Testing, as detailed in the Schedules bearing the Registration Numbers 279C and 281T, in compliance with the International Standard ISO/IEC 17025:2005 2nd Edition, “General Requirements for the Competence of Testing and Calibration Laboratories”.
Specialising in Medical Devices.
*Sales and Account Management.
*Marketing Evaluation Strategy &Implementation
DiaSorin Ireland (formerly Biotrin International) has a very successful history of developing niche Immuno Assays, some of which became best-in-class worldwide from both a quality and commercial standpoint. These skills have more recently been transferred into Molecular Diagnostic Test and Instrument Development. DiaSorin Ireland’s core competencies lie in Product Development, Regulatory compliance, high quality and reliable Manufacturing. These skills are currently being applied to Molecular Diagnostic Product Development and Manufacturing, where it is anticipated, our success in Parvovirus Immuno Assays will be reproduced for Molecular Infectious Disease and Oncology.
Biotrin was founded in 1992 to provide Immuno Assay Tests for the Clinical Lab and Research Scientist. The business was focused on two specific areas: Infectious Disease and Biomarkers of Organ and Tissue Damage. Biotrin licensed the technology for an Immuno Assay to detect Antibodies against Parvovirus B19 from Leiden University in the Netherlands and the NIH in USA. The virus is very important in pregnancy where lack of immunity in the mother can present a very significant risk to the foetus. During the 1990’s Biotrin built a very strong position in Parvovirus testing worldwide, eventually capturing 80% of the total testing market. In 1999 FDA clearance was received for two Parvovirus Assays, making them the first (and still the only) Parvovirus Assays to be approved for sale in the USA. The manufacturing site in Dublin was inspected by FDA as part of the approval process and since then has been inspected a further 5 times. In 2008 the Infectious Disease part of Biotrin was acquired by DiaSorin S.p.A (The Biomarker business was spun out to a separate company, Argutus Medical, prior to the sale). The Parvovirus Assays were adapted onto the LIAISON® Platform and launched in Jan 2010. Biotrin continued to manufacture the Microtitre plate Parvovirus Assay but Biotrin’s R&D team converted from Immunoassay Development to Molecular Development. The LAMP Technology for Nucleic Acid Detection, which was licensed by DiaSorin from the Eiken Chemical Company in Japan, was transferred to Dublin in 2009, along with some key staff from DiaSorin’s Research Center in Milan. In order to accommodate the new Molecular Manufacturing requirements, a new facility was sourced and re-developed in Dublin and this was opened in Sept. 2011. A portfolio of Infectious Disease and Oncology products, along with an Analyser (LIAISON® IAM) is under development and the initial Infectious Disease Assays (VZV, BKV, Parvovirus, Toxoplasma and CMV) were launched, along with the LIAISON® IAM, since Oct 2012. Biotrin changed its name to DiaSorin Ireland Ltd in Oct. 2012.
“ Bringing Innovation to Intervention”
Ducit Medical was founded with a view to design and develop innovative technologies for the interventional cardiology market. We are currently in an R&D phase with the first product(s) due to launch in June 2019.
TG Eakin Limited is a medical device manufacturer, dedicated to the production of high-quality skin protection products for use in stoma and wound care. Still a family owned and run business, TG Eakin Limited always ensures that patient needs are incorporated into our product design, providing comfort, protection and ease of use.
- Electramed markets and distributes medical and pharmaceutical products, and was established in 1972 by Eddie O’Grady MPSI. At start up, the core business involved selling tablet counting machines to retail and hospital pharmacies. This soon diversified into other medical products, firstly to the pharmacy sector, and later to private & public hospitals.
- In the early years, Electramed’s business was equally divided between the sales of prescription medicines, and supply of medical consumables and equipment. Today hospital business accounts for the majority of company activity, supplying a mixture of medical devices, medicines and equipment.
- Specialist markets include interventional radiology, nuclear medicine, orthopaedics and pharmacy.
- Geographically, Electramed operates on the island of Ireland and currently has a staff of 14.
- Website http://www.electramed.ie